Terms: = Endocrine gland cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
96 results:
1. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
2. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
[TBL] [Abstract] [Full Text] [Related]
3. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
4. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA; Melisi D; Macarulla T; Pazo Cid R; Chandana SR; De La Fouchardière C; Dean A; Kiss I; Lee WJ; Goetze TO; Van Cutsem E; Paulson AS; Bekaii-Saab T; Pant S; Hubner RA; Xiao Z; Chen H; Benzaghou F; O'Reilly EM
Lancet; 2023 Oct; 402(10409):1272-1281. PubMed ID: 37708904
[TBL] [Abstract] [Full Text] [Related]
5. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.
Kim JH; Lee Y; Kim DY; Kim S; Seo SS; Kang S; Park SY; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e3. PubMed ID: 37681357
[TBL] [Abstract] [Full Text] [Related]
6. Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma.
Jiang N; Jiao B; Zhang L; Li J; Li Y; Lin C
Ann Med; 2023 Dec; 55(1):2232372. PubMed ID: 37435919
[TBL] [Abstract] [Full Text] [Related]
7. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
8. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
9. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
10. Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2.
Cao W; Tian R; Pan R; Sun B; Xiao C; Chen Y; Zeng Z; Lei S
Bioengineered; 2022 Apr; 13(4):8643-8656. PubMed ID: 35322742
[TBL] [Abstract] [Full Text] [Related]
11. HNRNPC regulates rhoa to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer.
Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z
J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of risk factors and preventive strategies for intracranial infection after neuroendoscopic transnasal pituitary adenoma resection.
Huang X; Zhang X; Zhou J; Li G; Zheng G; Peng L; Yan Z; Chen S
BMC Neurosci; 2022 Jan; 23(1):1. PubMed ID: 34979913
[TBL] [Abstract] [Full Text] [Related]
13. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.
Hue JJ; Katayama ES; Markt SC; Elshami M; Saltzman J; Bajor D; Hosmer A; Mok S; Dumot J; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2022 Jul; 172(1):257-264. PubMed ID: 34839935
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of factors predicting loss of benefit provided by laparoscopic distal pancreatectomy compared to open approach.
Partelli S; Cinelli L; Andreasi V; Rancoita PMV; Pecorelli N; Tamburrino D; Crippa S; Falconi M
Updates Surg; 2022 Feb; 74(1):213-221. PubMed ID: 34687429
[TBL] [Abstract] [Full Text] [Related]
15. Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian cancer: A Clinical Study of 100 Patients.
Zhang J; Li XB; Ji ZH; Ma R; Bai WP; Li Y
Biomed Res Int; 2021; 2021():5533134. PubMed ID: 34258265
[TBL] [Abstract] [Full Text] [Related]
16. Ezrin Promotes the Proliferation, Migration, and Invasion of Ovarian cancer Cells.
Li MJ; Xiong D; Huang H; Wen ZY
Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
[TBL] [Abstract] [Full Text] [Related]
17. Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway.
Lin L; Wen J; Lin B; Chen H; Bhandari A; Qi Y; Zheng D; Wang O
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):481-491. PubMed ID: 33674820
[TBL] [Abstract] [Full Text] [Related]
18. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors.
Tavanti GS; Verdelli C; Morotti A; Maroni P; Guarnieri V; Scillitani A; Silipigni R; Guerneri S; Maggiore R; Mari G; Vicentini L; Dalino Ciaramella P; Vaira V; Corbetta S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670622
[TBL] [Abstract] [Full Text] [Related]
19. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of rhoa.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract] [Full Text] [Related]
20. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract] [Full Text] [Related]
[Next]
